RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Hisamitsu Pharmaceutical Co Stock

Hisamitsu Pharmaceutical Co ROE 2024

Hisamitsu Pharmaceutical Co ROE

0.05

Ticker

4530.T

ISIN

JP3784600003

WKN

864341

In 2024, Hisamitsu Pharmaceutical Co's return on equity (ROE) was 0.05, a 38.24% increase from the 0.04 ROE in the previous year.

Hisamitsu Pharmaceutical Co Aktienanalyse

What does Hisamitsu Pharmaceutical Co do?

Hisamitsu Pharmaceutical Co Inc is a Japanese company that was founded in 1847. The company is known for its patches and other medical products, making it one of the largest pharmaceutical manufacturers in Japan. The company specializes in the development and production of pharmaceuticals, medical devices, and health and beauty products. They have four main business areas: pharmaceutical products, health products, medical devices, and cosmetics. In addition to their popular Salonpas patches, they also offer a range of other medications, health products, medical devices, and cosmetics. Hisamitsu is committed to improving health and well-being through innovation and collaboration with research institutions and universities. Hisamitsu Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Hisamitsu Pharmaceutical Co's Return on Equity (ROE)

Hisamitsu Pharmaceutical Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Hisamitsu Pharmaceutical Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Hisamitsu Pharmaceutical Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Hisamitsu Pharmaceutical Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Hisamitsu Pharmaceutical Co stock

What is the ROE (Return on Equity) of Hisamitsu Pharmaceutical Co this year?

The ROE of Hisamitsu Pharmaceutical Co this year is 0.05 undefined.

How has the Return on Equity (ROE) of Hisamitsu Pharmaceutical Co developed compared to the previous year?

The ROE of Hisamitsu Pharmaceutical Co has increased by 38.24% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Hisamitsu Pharmaceutical Co?

A high ROE indicates that Hisamitsu Pharmaceutical Co generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Hisamitsu Pharmaceutical Co?

A low ROE can indicate that Hisamitsu Pharmaceutical Co is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Hisamitsu Pharmaceutical Co affect the company?

A change in ROE (Return on Equity) of Hisamitsu Pharmaceutical Co can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Hisamitsu Pharmaceutical Co?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Hisamitsu Pharmaceutical Co?

Some factors that can influence Hisamitsu Pharmaceutical Co's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Hisamitsu Pharmaceutical Co pay?

Over the past 12 months, Hisamitsu Pharmaceutical Co paid a dividend of 44.5 JPY . This corresponds to a dividend yield of about 1.11 %. For the coming 12 months, Hisamitsu Pharmaceutical Co is expected to pay a dividend of 45.42 JPY.

What is the dividend yield of Hisamitsu Pharmaceutical Co?

The current dividend yield of Hisamitsu Pharmaceutical Co is 1.11 %.

When does Hisamitsu Pharmaceutical Co pay dividends?

Hisamitsu Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of September, March, September, March.

How secure is the dividend of Hisamitsu Pharmaceutical Co?

Hisamitsu Pharmaceutical Co paid dividends every year for the past 23 years.

What is the dividend of Hisamitsu Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 45.42 JPY are expected. This corresponds to a dividend yield of 1.13 %.

In which sector is Hisamitsu Pharmaceutical Co located?

Hisamitsu Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hisamitsu Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hisamitsu Pharmaceutical Co from 11/1/2024 amounting to 2 JPY, you needed to have the stock in your portfolio before the ex-date on 8/29/2024.

When did Hisamitsu Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of Hisamitsu Pharmaceutical Co in the year 2023?

In the year 2023, Hisamitsu Pharmaceutical Co distributed 42.75 JPY as dividends.

In which currency does Hisamitsu Pharmaceutical Co pay out the dividend?

The dividends of Hisamitsu Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Hisamitsu Pharmaceutical Co

Our stock analysis for Hisamitsu Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hisamitsu Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.